Parduman R Sharma Selected Research

Parduman R Sharma Research Topics

Disease

16	Neoplasms (Cancer) 09/2017 - 12/2008
4	Leukemia 01/2014 - 03/2013
3	Pancreatic Neoplasms (Pancreatic Cancer) 01/2018 - 09/2016
2	Alzheimer Disease (Alzheimer's Disease) 11/2021 - 10/2019
2	Gout 01/2017 - 10/2016
2	Colonic Neoplasms (Colon Cancer) 01/2017 - 03/2016
2	Familial Mediterranean Fever (Periodic Disease) 01/2017 - 10/2016
1	Neuroinflammatory Diseases 11/2021
1	Breast Neoplasms (Breast Cancer) 09/2017
1	Hepatocellular Carcinoma (Hepatoma) 01/2017
1	Mitochondrial Diseases (Mitochondrial Disease) 10/2016
1	Leukemia P388 10/2016
1	Retinoblastoma (Glioblastoma, Retinal) 12/2013
1	Glioblastoma (Glioblastoma Multiforme) 01/2013
1	Body Weight (Weight, Body) 07/2008

Drug/Important Bio-Agent (IBA)

4	Colchicine FDA LinkGeneric 01/2017 - 05/2015
4	boswellic acidIBA 09/2016 - 07/2012
3	AlkaloidsIBA 09/2017 - 10/2016
2	Amyloid beta-PeptidesIBA 11/2021 - 10/2019
2	Member 1 Subfamily B ATP Binding Cassette TransporterIBA 11/2021 - 01/2017
2	Betulinic AcidIBA 05/2016 - 05/2013
2	AcidsIBA 06/2013 - 07/2012
1	AMP-Activated Protein KinasesIBA 11/2021
1	thiazolyl blueIBA 11/2021
1	trans-sodium crocetinate (crocetin)IBA 11/2021
1	Beclin-1IBA 11/2021
1	Glycogen Synthase Kinase 3 betaIBA 11/2021
1	Regulatory-Associated Protein of mTORIBA 11/2021
1	Adenosine Triphosphate (ATP)IBA 11/2021
1	Amyloid (Amyloid Fibrils)IBA 11/2021
1	Carrier Proteins (Binding Protein)IBA 11/2021
1	Cathepsin BIBA 11/2021
1	Glial Fibrillary Acidic ProteinIBA 11/2021
1	Microtubule-Associated Proteins (Microtubule-Associated Protein 2)IBA 11/2021
1	Peptide Initiation Factors (Initiation Factor)IBA 11/2021
1	Peptides (Polypeptides)IBA 11/2021
1	Phosphotransferases (Kinase)IBA 11/2021
1	Proteins (Proteins, Gene)FDA Link 11/2021
1	Transcription Factors (Transcription Factor)IBA 11/2021
1	N-Methylaspartate (NMDA)IBA 11/2021
1	Protein Serine-Threonine Kinases (Protein-Serine-Threonine Kinase)IBA 11/2021
1	Ribosomal Protein S6 Kinases (S6 Kinase)IBA 11/2021
1	Sirolimus (Rapamycin)FDA Link 11/2021
1	Mitogen-Activated Protein KinasesIBA 11/2021
1	Low Density Lipoprotein Receptor-Related Protein-1 (LDL-Receptor Related Protein)IBA 11/2021
1	70-kDa Ribosomal Protein S6 Kinases (Ribosomal Protein S6 Kinases, 70 kDa)IBA 11/2021
1	Calcium-Calmodulin-Dependent Protein Kinase KinaseIBA 11/2021
1	lissamine rhodamine B (sulforhodamine B)IBA 11/2021
1	Cadherins (E-Cadherin)IBA 01/2018
1	fascaplysineIBA 09/2017
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 09/2017
1	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 09/2017
1	LipidsIBA 01/2017
1	Butyric Acid (Butanoic Acid)IBA 01/2017
1	boeravinone BIBA 01/2017
1	Reactive Oxygen Species (Oxygen Radicals)IBA 10/2016
1	Therapeutic UsesIBA 10/2016
1	Antimitotic AgentsIBA 10/2016
1	Cyclin D1IBA 05/2016
1	TriazolesIBA 05/2016
1	acetamideIBA 03/2016
1	Gemcitabine FDA Link 08/2015
1	Antineoplastic Agents (Antineoplastics)IBA 08/2015
1	Cytotoxins (Cytolysins)IBA 01/2014
1	tryptanthrineIBA 01/2014
1	2- (4- morpholinyl)- 8- phenyl- 4H- 1- benzopyran- 4- oneIBA 12/2013
1	Cell Cycle ProteinsIBA 12/2013
1	2- (2- amino- 3- methoxyphenyl)- 4H- 1- benzopyran- 4- oneIBA 12/2013
1	Cyclin EIBA 12/2013
1	Paclitaxel (Taxol)FDA LinkGeneric 03/2013
1	indoleIBA 03/2013
1	combretastatinIBA 03/2013
1	pyrimidineIBA 01/2013
1	Pentacyclic TriterpenesIBA 07/2012
1	Volatile Oils (Essential Oils)IBA 05/2009
1	matairesinolIBA 12/2008
1	LignansIBA 12/2008

Therapy/Procedure

2	Therapeutics 03/2016 - 07/2012
1	Aftercare (After-Treatment) 07/2008